confinis’ Post

confinis reposted this

View profile for Guillaume Saint-Pierre, graphic

Regulatory Affairs Senior Consultant

Revised MDCG 2023-3 Guidance Document, why does it matter? 🌐 New MDCG 2023-3 Rev.1 Guidance Released in November 2024: Strengthening Vigilance for Medical Devices and IVDs under MDR and IVDR In November 2024, the MDCG released its updated guidance, MDCG 2023-3 Rev.1, a critical document for the medical device and diagnostics industries. This update refines vigilance practices under the EU’s Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), making it a key resource for manufacturers. Here’s why it matters: 🔍 Clarity & Consistency: Unified definitions for vigilance terms across MDR and IVDR reduce ambiguities, ensuring accurate incident reporting. 💡 Enhanced Patient Safety: Clear guidelines for identifying and reporting serious incidents promote timely responses to risks impacting patient health. ⚙️ Improved Compliance: Updated definitions, timelines, and criteria support better compliance management, helping manufacturers meet obligations effectively. 🧬 IVD-Specific Considerations: Tailored examples for in vitro diagnostics address unique challenges like diagnostic errors and indirect patient harm. 🌍 Public Health Preparedness: New guidance on serious public health threats, such as device-related outbreaks or major product failures, supports proactive risk mitigation. 📊 Streamlined Reporting with Eudamed: Detailed instructions for Eudamed use facilitate efficient, transparent vigilance reporting across the EU. This release is a significant milestone for patient safety and regulatory alignment, helping our industry meet evolving standards. #MedicalDevices #IVDR #MDR #Vigilance #PatientSafety #HealthcareRegulation #Compliance #Eudamed

To view or add a comment, sign in

Explore topics